Plasma Cell Vulvitis: A Case Series and Follow-Up Study.
Journal
Journal of lower genital tract disease
ISSN: 1526-0976
Titre abrégé: J Low Genit Tract Dis
Pays: United States
ID NLM: 9704963
Informations de publication
Date de publication:
01 Apr 2023
01 Apr 2023
Historique:
pubmed:
17
2
2023
medline:
28
3
2023
entrez:
16
2
2023
Statut:
ppublish
Résumé
Plasma cell vulvitis (PCV) is a rare inflammatory vulvar condition. The aim of this study was to describe the natural history, treatment, impact on quality of life, and factors associated with poorer outcomes for PCV. A mixed-methods approach was used combining a retrospective case note review with a cross-sectional telephone questionnaire. All women diagnosed with PCV attending the vulvar disorders clinic at the Royal Women's Hospital between January 2011 and December 2020 were included. During the 10-year study period, 7,500 women were seen at the vulval disorders clinic, of whom 21 were diagnosed with PCV (0.28%). Of these women, 12 who were followed up for more than 12 months agreed to participate in the study. At a median of 5 years follow-up, there was variability in symptom severity, with more than half of the women still symptomatic with pain, precipitated by friction and dyspareunia, resulting in a moderate to large impact on quality of life. There were 5 women who were asymptomatic. Only 1 woman had a preexisting history of lichen planus and lichen sclerosus. Potent topical corticosteroids were identified as the preferred treatment. Women with PCV can remain symptomatic for many years with significant impacts on quality of life, which may consequently require long-term support and follow-up.
Identifiants
pubmed: 36794759
doi: 10.1097/LGT.0000000000000725
pii: 00128360-202304000-00014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
185-189Informations de copyright
Copyright © 2023, ASCCP.
Déclaration de conflit d'intérêts
The authors have declared they have no conflicts of interest.
Références
Kavanagh GM, Burton PA, Kennedy CT. Vulvitis chronica plasmacellularis (Zoon's vulvitis). Br J Dermatol 1993;129:92–3.
Zoon JJ. Chronic circumscribed balanitis with plasma cell infiltration. Ned Tijdschr Geneeskd 1950;94:1529–30.
Zoon JJ. Balanitis and vulvitis plasmacellularis. Dermatologica 1955;111:157.
Sattler S, Elsensohn AN, Mauskar MM, et al. Plasma cell vulvitis: a systematic review. Int J Womens Dermatol 2021;7:756–62.
Krapf JM, Cavallo K, Saleeb M, et al. Plasma cell vulvitis: a systematic review. J Low Genit Tract Dis 2021;25:312–7.
Virgili A, Borghi A, Minghetti S, et al. Comparative study on topical immunomodulatory and anti-inflammatory treatments for plasma cell vulvitis: long-term efficacy and safety. J Eur Acad Dermatol Venereol 2015;29:507–14.
Yun JSW, Veysey E. Plasma cell vulvitis: a systematic review of interventions. J Low Genit Tract Dis 2021;25:243–54.
Virgili A, Corazza M, Minghetti S, et al. Symptoms in plasma cell vulvitis: first observational cohort study on type, frequency and severity. Dermatology 2015;230:113–8.
Virgili A, Levratti A, Marzola A, et al. Retrospective histopathologic reevaluation of 18 cases of plasma cell vulvitis. J Reprod Med 2005;50:3–7.
Hindle E, Yell J, Andrew S, et al. Plasma cell vulvovaginitis—a further case. J Obstet Gynaecol 2006;26:382–3.
Goldstein AT, Christopher K, Burrows LJ. Plasma cell vulvitis: a rare cause of intractable vulvar pruritus. Arch Dermatol 2005;141:789–90.
Robinson JB, Im DD, Simmons-O'Brien E, et al. Etretinate: therapy for plasma cell vulvitis. Obstet Gynecol 1998;92:706.
Gurumurthy M, Cairns M, Cruickshank M. Case series of Zoon vulvitis. J Low Genit Tract Dis 2010;14:56–8.
Toeima E, Sule M, Warren R, et al. Diagnosis and treatment of Zoon's vulvitis. J Obstet Gynaecol 2011;31:473–5.